Bionano Genomics (NASDAQ:BNGO) Trading Down 3.8% – Here’s Why

Bionano Genomics, Inc. (NASDAQ:BNGO) shares traded down 3.8% during mid-day trading on Monday . The company traded as low as $2.68 and last traded at $2.79. 54,663 shares were traded during mid-day trading, a decline of 32% from the average session volume of 80,189 shares. The stock had previously closed at $2.90.

Bionano Genomics Price Performance

The business has a fifty day moving average of $4.85 and a two-hundred day moving average of $13.14. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.99 and a current ratio of 1.43. The firm has a market capitalization of $7.63 million, a price-to-earnings ratio of -0.02 and a beta of 2.24.

Hedge Funds Weigh In On Bionano Genomics

Several institutional investors and hedge funds have recently made changes to their positions in the company. Carret Asset Management LLC grew its position in shares of Bionano Genomics by 39.9% during the 4th quarter. Carret Asset Management LLC now owns 119,000 shares of the company’s stock worth $34,000 after purchasing an additional 33,945 shares in the last quarter. XTX Topco Ltd acquired a new position in Bionano Genomics in the 4th quarter valued at $45,000. Renaissance Technologies LLC bought a new stake in shares of Bionano Genomics during the 4th quarter valued at $46,000. Jane Street Group LLC bought a new stake in shares of Bionano Genomics during the 4th quarter valued at $118,000. Finally, Geode Capital Management LLC grew its holdings in shares of Bionano Genomics by 47.3% during the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock worth $401,000 after purchasing an additional 283,639 shares in the last quarter. Institutional investors and hedge funds own 11.35% of the company’s stock.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.